AI-analyzed blood test could predict neurodegenerative disease progression

Written by Heather Jones, Assistant Editor

Researchers at The Neuro (Montreal Neurological Institute and Hospital, Canada) and the Ludmer Centre of McGill University (Montreal, Canada) have used an artificial intelligence algorithm to analyze samples from individuals with Alzheimer’s and Huntington’s, in order to identify molecular patterns specific to these diseases. The results, published in Brain, could lead to a more individualized approach to neurodegenerative disease treatment. Most prevalent neurodegenerative disorders take decades to develop. Owing to a lack of long-term chronological data regarding neurodegenerative disease progression, along with the variation in disease progression and expression between individuals, it is often difficult to evaluate the effectiveness of...

To view the full article, please register now for access

It's completely free